• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Retrophin Inc

+ Add to Watchlist

RTRX:US

13.6000 USD 0.0900 0.67%

As of 20:10:00 ET on 08/28/2014.

Snapshot for Retrophin Inc (RTRX)

Open: 13.3700 Day's Range: 13.2810 - 13.8400 Volume: 117,730
Previous Close: 13.5100 52wk Range: 5.1100 - 24.2500 1-Yr Rtn: +126.67%

Stock Chart for RTRX

No chart data available.
  • RTRX:US 13.5800
  • 1D
  • 1M
  • 1Y
13.5100
Interactive RTRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RTRX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -4.2579
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 362.87
Shares Outstanding (M) 26.68
30 Day Average Volume 211,459
Price/Book (mrq) 335.2969
Price/Sale (ttm) 60.3979
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/18/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RTRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RTRX

Retrophin, Inc. is a biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. The Company is currently developing treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy and other catastrophic diseases.

Martin ShkreliCEO/FounderStephen J Aselage "Steve"President/COO
Marc L PanoffCFO/Chief Acctg OfficerHoracio PlotkinChief Medical Officer
More Company Profile & Key Executives for RTRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil